Job Locations US-OH-Cleveland

ID

2024-1622

Category

Commercial & Corporate Strategy

Position Type

Regular Full-Time

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold and Innovative.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients.

Join us, as we reshape the future.

Job Summary:

The Interventional Radiology-Oncology Coordinator (IROC) will be the primary point of contact for our interventional radiology (IR) customers and will be responsible for supporting the launch of our emerging skin cancer portfolio.

The IROC will report to the Senior Director/Director of Interventional Radiology-Oncology Coordinators and is a field-based role and will work in close collaboration with cross-functional teams, including Marketing, Sales, Oncology Nurse Educators, Training & Development, Medical Affairs, Market Access & Strategic Accounts, Legal, and Compliance.

A high level of emphasis will be placed on elevating confidence in the administration and handling of RP1, ensuring understanding of the patient journey between specialists while creating vocal advocacy and creating a positive first experience for the patient and all relevant stakeholders.

This is a field based position. Candidates must reside within the territory for which they are applying.

The role and responsibilities of the IROC will:

• Ensure Interventional Radiology Practice preparedness to administer and handle RP1
• Provide approved education on efficacy, safety, dosing, AE Management
• Advocate for Melanoma Tumor Board Attendance
• Attend and participate in IR specific conferences
• Understand referral patterns and potential impact to the patient journey across settings
• Provide RP1 logistical and operational guidance/support to the patient journey across settings
• Support integration into Electronic Medical Records
• Provide approved biosafety and handling education
• Provide guidance to inquiries on reimbursement and triage to cross function team as necessary
• Provide guidance on appropriate RP1 superficial injection techniques (lesion selection, dosing, Oncology coordination) as needed
• Provide on-site support of first RP1 administration (or on-demand as requested)
• Educate staff with respect to RP1 patient/ caregiver treatment discussions
  
  

Role Responsibilities

• Complete account profiles and create/execute engagement account plans
• Understand local referral patterns
• Coordinate with internal cross-functional partners on regional planning
• Deliver Branded and Unbranded Campaign and Injection Education
• Provide appropriate support of RP1 injection guidance
• Attend and participate in regional and national IR symposia and identify opportunities to partner with Replimune
• Support IR advisory board needs / content from field experiences
• Support the development of customer facing resources
• Maintain a comprehensive list of IRs who are prepared and willing to administer RP1

The IROC will embody our culture while maintaining accountability for gathering and sharing insights, strategic planning, and flawless execution.

Behaviors that are critical for this leader to display include an innovative mind-set, strategic thinking, strong collaboration and communication skills and relationship building.

The ideal candidate will have a deep background in Interventional Radiology, and preferably experience working for a medical device or Pharma/ Biotechnology organization (ideally within the skin cancer space), with an entrepreneurial spirit and willingness to play a hands-on role in supporting launch excellence.

Education:

• Bachelor’s Degree required; graduate degree a plus

Required Experience:

• Minimum of at least 5 years of experience in interventional radiology (IR suite experience and/or IR procedure expertise)
• Experience with; skin cancer and/or PD1 experience preferred
• Passionate about providing a first-rate customer experience to internal & external customers; strong ability to communicate with a data driven focus
• Excellent communication skills
• Strong time management skills including the ability to multi-task on various projects and to prioritize under fixed schedules in high pressure situations
• Preferred training as a RN, NP or PA
• MedTech/Pharma/Biotech Experience
• Must live within their territory
• Some weekday and weekend travel may be required

About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

We are an Equal Opportunity Employer.

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.

Share on your newsfeed